Clinical trial · Interventional
Trans-parenchymal Compressing Suture in Major Liver Resection
Application of Trans-parenchymal Compressing Suture in Major Liver Resection to Decrease Cutting Surface Related Complication.
NCT03215290CI-TRIAL-00028588completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Non-anatomical liver resection with appropriate resection margin was regarded as a potential curative treatment for selected major hepatic carcinoma due to preserving maximal normal liver, especially in cirrhotic patients. But occurrence of cutting surface related complications become a main challenge.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Carcinoma Resectable | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| TCS | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Trans-parenchymal compressing suture
- description
- TCS: After liver transection, check for active hemorrhage and visible sites of bile leakage of cutting surface by stainless gauze which covered up on the raw cutting surface for 5 minutes. For patients with any positive findings including bloodstain and (or) bile staining, the cutting surface was recognized as "not good" cutting surface and further trans-parenchymal compressing sutured, if possible, using a hepatic needle.
- interventionNames
- Procedure: TCS
- type
- NO_INTERVENTION
- label
- Exposed surface (ES)
- description
- 147 Patients with exposed surface (ES) were matched as control group. No TCS.
Primary outcomes (1)
- measure
- Cutting surface related complications
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. tumor size more than 5cm 2. non-anatomical liver resection; Exclusion Criteria: 1. intravascular infiltration with tumor embolus; 2. previous liver surgical treatment (e.g. microwave ablation; preoperative transcatheter arterial chemoembolization (TACE); 3. other concomitant extrahepatic procedures (e.g. splenectomy). 4. exposed Glisson Shealth, main hepatic veins or (and) retro-hepatic inferior vena cava.
References
Publications (0)
Data not yet available
No reference posted for this study.